Literature DB >> 2043477

Priming of normal human neutrophils by recombinant human growth hormone.

C J Wiedermann1, M Niedermühlbichler, D Geissler, H Beimpold, H Braunsteiner.   

Abstract

Growth hormone (GH) plays an important role in the development, maintenance and function of the immune system. Previous data has demonstrated that GH is also a newly defined macrophage-activating factor. Activation of polymorphonuclear neutrophils (PMN) by GH has not yet been examined. This paper presents studies demonstrating the effects of GH on the migratory behaviour and respiratory burst of PMN. In a modified Boyden chamber chemotaxis assay, GH did not stimulate PMN locomotion when added directly to the cells but potently inhibited formylpeptide-stimulated chemotaxis with effective concentrations in the picomolar range. The migration inhibition observed is known from studies on PMN priming-factors to be due to enhanced adhesiveness of PMN to artificial surfaces such as nitrocellulose, suggesting that GH stimulates PMN adhesiveness. Priming of PMN by GH was confirmed by direct demonstration of a stimulatory effect on reduction of nitroblue tetrazolium. These findings suggest that GH may be involved in the regulation of PMN functions.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2043477     DOI: 10.1111/j.1365-2141.1991.tb04376.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  8 in total

1.  Characterization of the priming effect by pituitary canine growth hormone on canine polymorphonuclear neutrophil granulocyte function.

Authors:  T K Petersen; C W Smith; A L Jensen
Journal:  Clin Diagn Lab Immunol       Date:  2000-03

2.  Inhibition of superoxide anion release from circulating neutrophils by L-arginine in man.

Authors:  C J Wiedermann; B Sitte; U Zilian; N Reinisch; H Beimpold; G Finkenstedt; H Braunsteiner
Journal:  Clin Investig       Date:  1993-12

3.  Role of growth hormone in maturation and activation of dendritic cells via miR-200a and the Keap1/Nrf2 pathway.

Authors:  Qiu-Liang Liu; Jiao Zhang; Xin Liu; Jing-Yao Gao
Journal:  Cell Prolif       Date:  2015-08-20       Impact factor: 6.831

4.  Inhibition of recombinant human growth hormone-induced and prolactin-induced activation of neutrophils by octreotide.

Authors:  C J Wiedermann; N Reinisch; M Niedermühlbichler; H Braunsteiner
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-03       Impact factor: 3.000

5.  Reduction in superoxide anion secretion and bactericidal activity of neutrophils from aged rats: reversal by the combination of gamma interferon and growth hormone.

Authors:  Y K Fu; S Arkins; Y M Li; R Dantzer; K W Kelley
Journal:  Infect Immun       Date:  1994-01       Impact factor: 3.441

6.  Priming of polymorphonuclear neutrophils by atrial natriuretic peptide in vitro.

Authors:  C J Wiedermann; M Niedermühlbichler; H Braunsteiner; C J Widermann
Journal:  J Clin Invest       Date:  1992-05       Impact factor: 14.808

7.  In vivo administration of recombinant growth hormone or gamma interferon activities macrophages: enhanced resistance to experimental Salmonella typhimurium infection is correlated with generation of reactive oxygen intermediates.

Authors:  C K Edwards; S M Ghiasuddin; L M Yunger; R M Lorence; S Arkins; R Dantzer; K W Kelley
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

8.  Growth Hormone (GH) Deficient Mice With GHRH Gene Ablation Are Severely Deficient in Vaccine and Immune Responses Against Streptococcus pneumoniae.

Authors:  Khalil Farhat; Gwennaëlle Bodart; Chantal Charlet-Renard; Christophe J Desmet; Michel Moutschen; Yves Beguin; Frédéric Baron; Pierrette Melin; Pascale Quatresooz; Anne-Simone Parent; Daniel Desmecht; Jean-Claude Sirard; Roberto Salvatori; Henri Martens; Vincent G Geenen
Journal:  Front Immunol       Date:  2018-10-02       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.